Literature
(5 items) | | human disease | PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas.
Lee JW, Soung YH, Kim SY, Lee HW, Park WS, Nam SW, Kim SH, Lee JY, Yoo NJ, Lee SH
Oncogene. 2005;24;1477-80. PMID: 15608678
| Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms.
Calin GA, di Iasio MG, Caprini E, Vorechovsky I, Natali PG, Sozzi G, Croce CM, Barbanti-Brodano G, Russo G, Negrini M
Oncogene. 2000;19;1191-5. PMID: 10713707 DOI: 10.1038/sj.onc.1203389
|
| | PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma.
Saal LH, Holm K, Maurer M, Memeo L, Su T, Wang X, Yu JS, Malmström PO, Mansukhani M, Enoksson J, Hibshoosh H, Borg A, Parsons R
Cancer Res. 2005;65;2554-9. PMID: 15805248
| PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma.
Buttitta F, Felicioni L, Barassi F, Martella C, Paolizzi D, Fresu G, Salvatore S, Cuccurullo F, Mezzetti A, Campani D, Marchetti A
J Pathol. 2006;208;350-5. PMID: 16353168 DOI: 10.1002/path.1908
| Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women.
Maruyama N, Miyoshi Y, Taguchi T, Tamaki Y, Monden M, Noguchi S
Clin Cancer Res. 2007;13;408-14. PMID: 17202311 DOI: 10.1158/1078-0432.CCR-06-0267
|
| |
